Leukemia & Lymphoma, Volume 55, Issue 12 (2014)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Leukemia & Lymphoma, Volume 55, Issue 12 (2014)

See all volumes and issues
Vol 65, 2024 Vol 64, 2023 Vol 63, 2022 Vol 62, 2021 Vol 61, 2020 Vol 60, 2019 Vol 59, 2018 Vol 58, 2017 Vol 57, 2016 Vol 56, 2015 Volume 55, 2014 Vol 54, 2013 Vol 53, 2012 Vol 52, 2011 Vol 51, 2010 Vol 50, 2009 Vol 49, 2008 Vol 48, 2007 Vol 47, 2006 Vol 46, 2005 Vol 45, 2004 Vol 44, 2003 Vol 43, 2002 Vol 42, 2001 Vol 41, 2001 Vol 40, 2000-2001 Vol 39, 2000 Vol 38, 2000 Vol 37, 2000 Vol 36, 1999-2000 Vol 35, 1999 Vol 34, 1999 Vol 33, 1999 Vol 32, 1998-1999 Vol 31, 1998 Vol 30, 1998 Vol 29, 1998 Vol 28, 1997-1998 Vol 27, 1997 Vol 26, 1997 Vol 25, 1997 Vol 24, 1996-1997 Vol 23, 1996 Vol 22, 1996 Vol 21, 1996 Vol 20, 1995-1996 Vol 19, 1995 Vol 18, 1995 Vol 17, 1995 Vol 16, 1995 Vol 15, 1995 Vol 16, 1995 Vol 15, 1995 Vol 14, 1994 Vol 13, 1994 Vol 12, 1993-1994 Vol 11, 1993 Vol 10, 1993 Vol 9, 1993 Vol 8, 1992 Vol 7, 1992 Vol 6, 1991-1992 Vol 5, 1991 Vol 4, 1991 Vol 3, 1990-1991 Vol 2, 1990 Vol 1, 1989-1990
Download citations Download PDFs

Commentaries on selected articles in this issue

Article Commentary
Is Bcl-2 a valid target in the treatment of indolent non-Hodgkin lymphoma?
Elizabeth A. Brem & Matthew S. Davids
Pages: 2675-2677
Published online: 27 Jun 2014
First Page PreviewforIs Bcl-2 a valid target in the treatment of indolent non-Hodgkin lymphoma? | Full Text | References | PDF (92.5 KB) | Supplemental
  • 1150 Views
  • 1 CrossRef citations
  • 0Altmetric
Free Access

Commentary

Article Commentary
Generic imatinib: the real-deal or just a deal?
Vikram Mathews
Pages: 2678-2680
Published online: 06 May 2014
First Page PreviewforGeneric imatinib: the real-deal or just a deal? | Full Text | References | PDF (265.6 KB) | Supplemental
  • 3058 Views
  • 13 CrossRef citations
  • 0Altmetric
Free Access
Article Commentary
The growing link between multiple myeloma and myeloid derived suppressor cells
Tamar Tadmor
Pages: 2681-2682
Published online: 06 May 2014
CitationforThe growing link between multiple myeloma and myeloid derived suppressor cells | Full Text | References | PDF (85.6 KB) | Supplemental
  • 545 Views
  • 5 CrossRef citations
  • 0Altmetric
Free Access
Article Commentary
Infection in chronic lymphocytic leukemia: parsimony has its limits
Paul M. Barr & Clive S. Zent
Pages: 2683-2684
Published online: 16 May 2014
CitationforInfection in chronic lymphocytic leukemia: parsimony has its limits | Full Text | References | PDF (84.8 KB) | Supplemental
  • 3754 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

Reviews

Review Article
Therapeutic options for patients with polycythemia vera and essential thrombocythemia refractory/resistant to hydroxyurea
Matjaz Sever, Kate J. Newberry & Srdan Verstovsek
Pages: 2685-2690
Published online: 17 Mar 2014
AbstractforTherapeutic options for patients with polycythemia vera and essential thrombocythemia refractory/resistant to hydroxyurea | Full Text | References | PDF (135.7 KB) | Supplemental
  • 845 Views
  • 20 CrossRef citations
  • 0Altmetric

Review Article

Review Article
Prognostic significance of Tet methylcytosine dioxygenase 2 (TET2) gene mutations in adult patients with acute myeloid leukemia: a meta-analysis
Wen-Jian Liu, Xiao-Hong Tan, Xiu-Ping Luo, Bao-Ping Guo, Zhou-Ji Wei, Qing Ke, Sha He & Hong Cen
Pages: 2691-2698
Published online: 31 Mar 2014
AbstractforPrognostic significance of Tet methylcytosine dioxygenase 2 (TET2) gene mutations in adult patients with acute myeloid leukemia: a meta-analysis | Full Text | References | PDF (974.6 KB) | Supplemental
  • 690 Views
  • 38 CrossRef citations
  • 0Altmetric
Review Article
Role of spleen tyrosine kinase in the pathogenesis of chronic lymphocytic leukemia
Gege Feng & Xin Wang
Pages: 2699-2705
Published online: 18 Mar 2014
AbstractforRole of spleen tyrosine kinase in the pathogenesis of chronic lymphocytic leukemia | Full Text | References | PDF (322.5 KB) | Supplemental
  • 353 Views
  • 7 CrossRef citations
  • 0Altmetric

Clinical Dilemmas

Article
Is there a role for JAK inhibitors in BCR-ABL1-negative myeloproliferative neoplasms other than myelofibrosis?
Animesh Pardanani & Ayalew Tefferi
Pages: 2706-2711
Published online: 18 Dec 2014
AbstractforIs there a role for JAK inhibitors in BCR-ABL1-negative myeloproliferative neoplasms other than myelofibrosis? | Full Text | References | PDF (145.7 KB)
  • 1048 Views
  • 4 CrossRef citations
  • 0Altmetric

Original Articles: Clinical

Review Article
Effectiveness and safety of thiotepa as conditioning treatment prior to stem cell transplant in patients with central nervous system lymphoma
Madzouka B. Kokolo, Dean Fergusson, Joseph O’Neill, Jason Tay, Alan T. Tinmouth, Douglas Stewart & Chris Bredeson
Pages: 2712-2720
Published online: 26 Mar 2014
AbstractforEffectiveness and safety of thiotepa as conditioning treatment prior to stem cell transplant in patients with central nervous system lymphoma | Full Text | References | PDF (722.8 KB) | Supplemental
  • 615 Views
  • 7 CrossRef citations
  • 0Altmetric

Research Article

Article
Human leukocyte antigen-DR expression on flow cytometry and tumor-associated macrophages in diffuse large B-cell lymphoma treated by rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone therapy: retrospective cohort study
Wataru Yamamoto, Naoya Nakamura, Naoto Tomita, Kengo Takeuchi, Yoshimi Ishii, Hiroyuki Takahashi, Reina Watanabe, Hirotaka Takasaki, Shigeki Motomura, Shoichi Kobayashi, Tomoyuki Yokose, Yoshiaki Ishigatsubo & Rika Sakai
Pages: 2721-2727
Published online: 19 Mar 2014
AbstractforHuman leukocyte antigen-DR expression on flow cytometry and tumor-associated macrophages in diffuse large B-cell lymphoma treated by rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone therapy: retrospective cohort study | Full Text | References | PDF (842.8 KB) | Supplemental
  • 403 Views
  • 11 CrossRef citations
  • 0Altmetric
Article
Peripheral blood absolute lymphocyte/monocyte ratio during rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone treatment cycles predicts clinical outcomes in diffuse large B-cell lymphoma
Luis F. Porrata, Kay M. Ristow, Thomas M. Habermann, Thomas E. Witzig, Joseph P. Colgan, David J. Inwards, Stephen M. Ansell, Ivana N. Micallef, Patrick B. Johnston, Grzegorz Nowakowski, Carrie A. Thompson & Svetomir N. Markovic
Pages: 2728-2738
Published online: 19 Mar 2014
AbstractforPeripheral blood absolute lymphocyte/monocyte ratio during rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone treatment cycles predicts clinical outcomes in diffuse large B-cell lymphoma | Full Text | References | PDF (1.9 MB) | Supplemental
  • 542 Views
  • 36 CrossRef citations
  • 0Altmetric
Article
A prospective study of an alemtuzumab containing reduced-intensity allogeneic stem cell transplant program in patients with poor-risk and advanced lymphoid malignancies
Craig S. Sauter, Joanne F. Chou, Esperanza B. Papadopoulos, Miguel-Angel Perales, Ann A. Jakubowski, James W. Young, Michael Scordo, Sergio Giralt & Hugo Castro-Malaspina
Pages: 2739-2747
Published online: 20 Mar 2014
AbstractforA prospective study of an alemtuzumab containing reduced-intensity allogeneic stem cell transplant program in patients with poor-risk and advanced lymphoid malignancies | Full Text | References | PDF (219.4 KB) | Supplemental
  • 215 Views
  • 8 CrossRef citations
  • 0Altmetric
Article
Extranodal natural killer/T cell lymphomas with extranasal disease in non-endemic regions are disseminated or have nasal primary: a study of 84 cases from India
Tanuja Shet, Pallavi Suryawanshi, Sridhar Epari, Manju Sengar, Venkatesh Rangarajan, Hari Menon & Siddharatha Laskar
Pages: 2748-2753
Published online: 03 Apr 2014
AbstractforExtranodal natural killer/T cell lymphomas with extranasal disease in non-endemic regions are disseminated or have nasal primary: a study of 84 cases from India | Full Text | References | PDF (880.5 KB) | Supplemental
  • 163 Views
  • 17 CrossRef citations
  • 0Altmetric
Article
Prolonged progression-free survival and preserved quality of life in the Canadian prospective study of tositumomab and iodine131-tositumomab for previously treated, rituximab-exposed, indolent non-Hodgkin lymphoma
Harold J. Olney, Marni A. Freeman, Douglas A. Stewart, Joy E. Mangel, Darrell J. White & Julia O. Elia-Pacitti
Pages: 2754-2760
Published online: 03 Apr 2014
AbstractforProlonged progression-free survival and preserved quality of life in the Canadian prospective study of tositumomab and iodine131-tositumomab for previously treated, rituximab-exposed, indolent non-Hodgkin lymphoma | Full Text | References | PDF (436.6 KB) | Supplemental
  • 261 Views
  • 7 CrossRef citations
  • 0Altmetric
Article
A phase I/II study of the pan Bcl-2 inhibitor obatoclax mesylate plus bortezomib for relapsed or refractory mantle cell lymphoma
André Goy, Francisco J. Hernandez-Ilzaliturri, Brad Kahl, Peggy Ford, Ewelina Protomastro & Mark Berger
Pages: 2761-2768
Published online: 06 May 2014
AbstractforA phase I/II study of the pan Bcl-2 inhibitor obatoclax mesylate plus bortezomib for relapsed or refractory mantle cell lymphoma | Full Text | References | PDF (147.7 KB) | Supplemental
  • 325 Views
  • 38 CrossRef citations
  • 0Altmetric
Article
Cladribine prolongs progression-free survival and time to second treatment compared to fludarabine and high-dose chlorambucil in chronic lymphocytic leukemia
Stephen P. Mulligan, Karin Karlsson, Mats Strömberg, Viggo Jønsson, Devinder Gill, Jens Hammerström, Mark Hertzberg, Roger McLennan, Bertil Uggla, John Norman, Jonas Wallvik, Gunnel Sundström, Hemming Johansson, Yvonne Brandberg, Jan Liliemark, Gunnar Juliusson & for the Scandinavian and Australasian Leukaemia Lymphoma Groups (Allg)
Pages: 2769-2777
Published online: 16 Apr 2014
AbstractforCladribine prolongs progression-free survival and time to second treatment compared to fludarabine and high-dose chlorambucil in chronic lymphocytic leukemia | Full Text | References | PDF (255.4 KB) | Supplemental
  • 477 Views
  • 7 CrossRef citations
  • 0Altmetric
Article
The impact of race, ethnicity, age and sex on clinical outcome in chronic lymphocytic leukemia: a comprehensive Surveillance, Epidemiology, and End Results analysis in the modern era
Chadi Nabhan, Briseis Aschebrook-Kilfoy, Brian C.-H. Chiu, Sonali M. Smith, Tait D. Shanafelt, Andrew M. Evens & Neil E. Kay
Pages: 2778-2784
Published online: 03 Apr 2014
AbstractforThe impact of race, ethnicity, age and sex on clinical outcome in chronic lymphocytic leukemia: a comprehensive Surveillance, Epidemiology, and End Results analysis in the modern era | Full Text | References | PDF (299.6 KB) | Supplemental
  • 774 Views
  • 27 CrossRef citations
  • 0Altmetric
Article
NOTCH1, SF3B1, BIRC3 and TP53 mutations in patients with chronic lymphocytic leukemia undergoing first-line treatment: correlation with biological parameters and response to treatment
Sabina Chiaretti, Marilisa Marinelli, Ilaria Del Giudice, Silvia Bonina, Alfonso Piciocchi, Monica Messina, Marco Vignetti, Davide Rossi, Valeria Di Maio, Francesca Romana Mauro, Anna Guarini, Gianluca Gaidano & Robin Foà
Pages: 2785-2792
Published online: 06 Mar 2014
AbstractforNOTCH1, SF3B1, BIRC3 and TP53 mutations in patients with chronic lymphocytic leukemia undergoing first-line treatment: correlation with biological parameters and response to treatment | Full Text | References | PDF (341.8 KB) | Supplemental
  • 959 Views
  • 41 CrossRef citations
  • 0Altmetric
Article
Association between reduced folate carrier G80A polymorphism and methotrexate toxicity in childhood acute lymphoblastic leukemia: a meta-analysis
Hai-Rong He, Ping Liu, Gong-Hao He, Wei-Hua Dong, Mao-Yi Wang, Ya-Lin Dong & Jun Lu
Pages: 2793-2800
Published online: 03 Apr 2014
AbstractforAssociation between reduced folate carrier G80A polymorphism and methotrexate toxicity in childhood acute lymphoblastic leukemia: a meta-analysis | Full Text | References | PDF (911.4 KB) | Supplemental
  • 357 Views
  • 14 CrossRef citations
  • 0Altmetric
Article
Excellent outcomes for adolescents and adults with acute lymphoblastic leukemia and lymphoma without allogeneic stem cell transplant: the FRALLE-93 pediatric protocol
Jay Hocking, Anthony P. Schwarer, Robin Gasiorowski, Sush Patil, Sharon Avery, John Gibson, Harry Iland, P. Joy Ho, Douglas Joshua, Jenny Muirhead, Hock Lai & Ian Irving
Pages: 2801-2807
Published online: 19 Mar 2014
AbstractforExcellent outcomes for adolescents and adults with acute lymphoblastic leukemia and lymphoma without allogeneic stem cell transplant: the FRALLE-93 pediatric protocol | Full Text | References | PDF (303.7 KB) | Supplemental
  • 633 Views
  • 15 CrossRef citations
  • 0Altmetric
Article
Prognostic index for relapsed acute leukemia after allogeneic stem cell transplant
Kenji Matsumoto, Wataru Yamamoto, Eriko Ogusa, Yoshiaki Ishigatsubo & Heiwa Kanamori
Pages: 2808-2812
Published online: 02 Apr 2014
AbstractforPrognostic index for relapsed acute leukemia after allogeneic stem cell transplant | Full Text | References | PDF (214.7 KB) | Supplemental
  • 169 Views
  • 9 CrossRef citations
  • 0Altmetric
Article
Deleterious effects of non-branded versions of imatinib used for the treatment of patients with chronic myeloid leukemia in chronic phase: a case series on an escalating issue impacting patient safety
Domingo Saavedra & Fabiola Vizcarra
Pages: 2813-2816
Published online: 17 Jun 2014
AbstractforDeleterious effects of non-branded versions of imatinib used for the treatment of patients with chronic myeloid leukemia in chronic phase: a case series on an escalating issue impacting patient safety | Full Text | References | PDF (115.4 KB) | Supplemental
  • 417 Views
  • 16 CrossRef citations
  • 0Altmetric
Article
High expression of suppressor of cytokine signaling-2 predicts poor outcome in pediatric acute myeloid leukemia: a report from the Children's Oncology Group
George S. Laszlo, Rhonda E. Ries, Chelsea J. Gudgeon, Kimberly H. Harrington, Todd A. Alonzo, Robert B. Gerbing, Susana C. Raimondi, Betsy A. Hirsch, Alan S. Gamis, Soheil Meshinchi & Roland B. Walter
Pages: 2817-2821
Published online: 24 Mar 2014
AbstractforHigh expression of suppressor of cytokine signaling-2 predicts poor outcome in pediatric acute myeloid leukemia: a report from the Children's Oncology Group | Full Text | References | PDF (224.2 KB) | Supplemental
  • 196 Views
  • 16 CrossRef citations
  • 0Altmetric
Article
The effect of calcium channel blockers on the outcome of acute myeloid leukemia
Young Kwang Chae, Anastasios Dimou, Sherry Pierce, Hagop Kantarjian & Michael Andreeff
Pages: 2822-2829
Published online: 29 Apr 2014
AbstractforThe effect of calcium channel blockers on the outcome of acute myeloid leukemia | Full Text | References | PDF (1.8 MB) | Supplemental
  • 372 Views
  • 14 CrossRef citations
  • 0Altmetric
Article
Prospective single-center study of chronic myeloid leukemia in chronic phase: switching from branded imatinib to a copy drug and back
Alaa Fadhil Alwan, Bassam F. Matti, Aladdin S. Naji, Abdulsalam H. Muhammed & Manal A. Abdulsahib
Pages: 2830-2834
Published online: 22 Apr 2014
AbstractforProspective single-center study of chronic myeloid leukemia in chronic phase: switching from branded imatinib to a copy drug and back | Full Text | References | PDF (444.2 KB) | Supplemental
  • 484 Views
  • 17 CrossRef citations
  • 0Altmetric
Article
Prevalence and risk factors for depression in newly diagnosed patients with POEMS syndrome
Lu Zhang, Yin-Lei Zhou, Wei Zhang, Ming-Hui Duan, Xin-Xin Cao, Dao-Bin Zhou & Jian Li
Pages: 2835-2841
Published online: 17 Mar 2014
AbstractforPrevalence and risk factors for depression in newly diagnosed patients with POEMS syndrome | Full Text | References | PDF (136.7 KB) | Supplemental
  • 208 Views
  • 10 CrossRef citations
  • 0Altmetric
Article
Thalidomide, clarithromycin, lenalidomide and dexamethasone therapy in newly diagnosed, symptomatic multiple myeloma
Tomer M. Mark, Isaac A. Bowman, Adriana C. Rossi, Manan Shah, Melissa Rodriguez, Ryann Quinn, Roger N. Pearse, Faiza Zafar, Karen Pekle, David Jayabalan, Scott Ely, Morton Coleman, Selina Chen-Kiang & Ruben Niesvizky
Pages: 2842-2849
Published online: 25 Mar 2014
AbstractforThalidomide, clarithromycin, lenalidomide and dexamethasone therapy in newly diagnosed, symptomatic multiple myeloma | Full Text | References | PDF (333.4 KB) | Supplemental
  • 890 Views
  • 7 CrossRef citations
  • 0Altmetric
Article
Disease-specific survival for patients with multiple myeloma: significant improvements over time in all age groups
Edward Libby, David Garcia, Dulcinea Quintana, M. Houman Fekrazad, Julie Bauman, Ala Ebaid, Robert Hromas, Ian Rabinowitz & Charles Wiggins
Pages: 2850-2857
Published online: 09 May 2014
AbstractforDisease-specific survival for patients with multiple myeloma: significant improvements over time in all age groups | Full Text | References | PDF (405.5 KB) | Supplemental
  • 530 Views
  • 16 CrossRef citations
  • 0Altmetric
Article
The emergence of vancomycin-resistant enterococcal bacteremia in hematopoietic stem cell transplant recipients
Michael J. Satlin, Rosemary Soave, Alexandra C. Racanelli, Tsiporah B. Shore, Koen van Besien, Stephen G. Jenkins & Thomas J. Walsh
Pages: 2858-2865
Published online: 24 Mar 2014
AbstractforThe emergence of vancomycin-resistant enterococcal bacteremia in hematopoietic stem cell transplant recipients | Full Text | References | PDF (351.8 KB) | Supplemental
  • 351 Views
  • 30 CrossRef citations
  • 0Altmetric
Article
Clofarabine-associated acute kidney injury in patients undergoing hematopoietic stem cell transplant
Camille R. Petri, Peter H. O’Donnell, Hongyuan Cao, Andrew S. Artz, Wendy Stock, Amittha Wickrema, Marjie Hard & Koen van Besien
Pages: 2866-2873
Published online: 27 May 2014
AbstractforClofarabine-associated acute kidney injury in patients undergoing hematopoietic stem cell transplant | Full Text | References | PDF (2.4 MB) | Supplemental
  • 292 Views
  • 14 CrossRef citations
  • 0Altmetric
Article
The impact of prehydration on the clearance and toxicity of high-dose methotrexate for pediatric patients
Michael Karremann, Judith Sauerbier, Caroline Meier, Cornelia Vetter, Henriette Schneider, Bernd Buchholz, Susanne Mildenberger & Matthias Dürken
Pages: 2874-2878
Published online: 02 Apr 2014
AbstractforThe impact of prehydration on the clearance and toxicity of high-dose methotrexate for pediatric patients | Full Text | References | PDF (464.3 KB) | Supplemental
  • 375 Views
  • 8 CrossRef citations
  • 0Altmetric
Article
Patient-driven discontinuation of tyrosine kinase inhibitors: single institution experience
Ohad Benjamini, Hagop Kantarjian, Mary Beth Rios, Elias Jabbour, Susan O’Brien, Preetesh Jain, Marylou Cardenas-Turanzas, Stefan Faderl, Guillermo Garcia-Manero, Farhad Ravandi, Gautam Borthakur, Alfonso Quintas-Cardama & Jorge Cortes
Pages: 2879-2886
Published online: 10 Sep 2013
AbstractforPatient-driven discontinuation of tyrosine kinase inhibitors: single institution experience | Full Text | References | PDF (1.4 MB) | Supplemental
  • 460 Views
  • 25 CrossRef citations
  • 0Altmetric
Article
Clinical impact of contrast-enhanced computed tomography combined with low-dose 18F-fluorodeoxyglucose positron emission tomography/computed tomography on routine lymphoma patient management
Julia Chalaye, Alain Luciani, Catalina Enache, Pauline Beaussart, Catherine Lhermite, Eva Evangelista, Myriam Sasanelli, Violaine Safar, Michel Meignan, Corinne Haioun, Alain Rahmouni & Emmanuel Itti
Pages: 2887-2892
Published online: 03 Apr 2014
AbstractforClinical impact of contrast-enhanced computed tomography combined with low-dose 18F-fluorodeoxyglucose positron emission tomography/computed tomography on routine lymphoma patient management | Full Text | References | PDF (140.1 KB) | Supplemental
  • 223 Views
  • 25 CrossRef citations
  • 0Altmetric

Original Articles: Research

Article
Myeloid derived suppressor cells are numerically, functionally and phenotypically different in patients with multiple myeloma
James Favaloro, Tulita Liyadipitiya, Ross Brown, Shihong Yang, Hayley Suen, Narelle Woodland, Najah Nassif, Derek Hart, Phillip Fromm, Claire Weatherburn, John Gibson, P. Joy Ho & Douglas Joshua
Pages: 2893-2900
Published online: 12 May 2014
AbstractforMyeloid derived suppressor cells are numerically, functionally and phenotypically different in patients with multiple myeloma | Full Text | References | PDF (2.2 MB) | Supplemental
  • 958 Views
  • 83 CrossRef citations
  • 0Altmetric

Research Article

Article
Eltrombopag can overcome the anti-megakaryopoietic effects of lenalidomide without increasing proliferation of the malignant myelodysplastic syndrome/acute myelogenous leukemia clone
Roni Tamari, Carolina Schinke, Tushar Bhagat, Michael Roth, Ira Braunschweig, Britta Will, Ulrich Steidl & Amit Verma
Pages: 2901-2906
Published online: 20 Mar 2014
AbstractforEltrombopag can overcome the anti-megakaryopoietic effects of lenalidomide without increasing proliferation of the malignant myelodysplastic syndrome/acute myelogenous leukemia clone | Full Text | References | PDF (951.4 KB) | Supplemental
  • 801 Views
  • 11 CrossRef citations
  • 0Altmetric
Article
Amplification of B cell receptor–Erk signaling by Rasgrf-1 overexpression in chronic lymphocytic leukemia
Wei Liao, Gwen Jordaan, Natalie Coriaty & Sanjai Sharma
Pages: 2907-2916
Published online: 02 Apr 2014
AbstractforAmplification of B cell receptor–Erk signaling by Rasgrf-1 overexpression in chronic lymphocytic leukemia | Full Text | References | PDF (879.5 KB) | Supplemental
  • 335 Views
  • 6 CrossRef citations
  • 0Altmetric
Article
A new model of LMP1–MYC interaction in B cell lymphoma
Evelena P. Ontiveros, Ahmad Halwani, Laura L. Stunz, Natalie Kamberos, Alicia K. Olivier, Siegfried Janz & Gail A. Bishop
Pages: 2917-2923
Published online: 23 Apr 2014
AbstractforA new model of LMP1–MYC interaction in B cell lymphoma | Full Text | References | PDF (1,012.7 KB) | Supplemental
  • 255 Views
  • 5 CrossRef citations
  • 0Altmetric
Article
Disruption of chromosomal locus 1p36 differentially modulates TAp73 and ΔNp73 expression in follicular lymphoma
Hesham M. Hassan, Michelle L. Varney, Smrati Jain, Dennis D. Weisenburger, Rakesh K. Singh & Bhavana J. Dave
Pages: 2924-2931
Published online: 06 May 2014
AbstractforDisruption of chromosomal locus 1p36 differentially modulates TAp73 and ΔNp73 expression in follicular lymphoma | Full Text | References | PDF (4.7 MB) | Supplemental
  • 180 Views
  • 3 CrossRef citations
  • 0Altmetric

Letters to the Editor

Letter
Sequential single-agent obatoclax mesylate (GX15–070MS) followed by combination with rituximab in patients with previously untreated follicular lymphoma
André Goy, Mark Berger, Peggy Ford, Tatyana Feldman, Anthony Mato, Colleen Bejot & Henry C. Fung
Pages: 2932-2934
Published online: 22 Apr 2014
First Page PreviewforSequential single-agent obatoclax mesylate (GX15–070MS) followed by combination with rituximab in patients with previously untreated follicular lymphoma | Full Text | References | PDF (152.4 KB) | Supplemental
  • 137 Views
  • 8 CrossRef citations
  • 0Altmetric

Letter

Letter
The efficacy of generic formulations of imatinib mesylate in the treatment of chronic myeloid leukemia
Ahmet Emre Eskazan, Tugrul Elverdi, Fevzi Firat Yalniz, Ayse Salihoglu, Muhlis Cem Ar, Seniz Ongoren Aydin, Zafer Baslar, Yildiz Aydin, Nukhet Tuzuner, Ugur Ozbek & Teoman Soysal
Pages: 2935-2937
Published online: 06 May 2014
First Page PreviewforThe efficacy of generic formulations of imatinib mesylate in the treatment of chronic myeloid leukemia | Full Text | References | PDF (103.3 KB) | Supplemental
  • 546 Views
  • 14 CrossRef citations
  • 0Altmetric
Letter
Epstein–Barr virus reactivation and hemophagocytic lymphohistiocytosis in a patient with chronic lymphocytic leukemia
Ming Y. Lim, Yuri Fedoriw, Hansa Ramanayake, Kenneth Zeitler, Lea Bardy & Stephan Moll
Pages: 2938-2941
Published online: 22 Apr 2014
First Page PreviewforEpstein–Barr virus reactivation and hemophagocytic lymphohistiocytosis in a patient with chronic lymphocytic leukemia | Full Text | References | PDF (588.9 KB) | Supplemental
  • 143 Views
  • 4 CrossRef citations
  • 0Altmetric
Letter
Methylenetetrahydrofolate reductase polymorphisms in myelodysplastic syndromes and therapy-related myeloid neoplasms
Marianna Criscuolo, Patrizia Chiusolo, Sabrina Giammarco, Manuela Giachelia, Luana Fianchi, Emiliano Fabiani, Giulia Falconi, Stefan Hohaus, Simona Sica, Giuseppe Leone & Maria Teresa Voso
Pages: 2942-2944
Published online: 22 Apr 2014
First Page PreviewforMethylenetetrahydrofolate reductase polymorphisms in myelodysplastic syndromes and therapy-related myeloid neoplasms | Full Text | References | PDF (151.8 KB) | Supplemental
  • 141 Views
  • 3 CrossRef citations
  • 0Altmetric
Letter
A new family with a germline ANKRD26 mutation and predisposition to myeloid malignancies
Rafael Marquez, Andrew Hantel, Rachelle Lorenz, Barbara Neistadt, Jerry Wong, Jane E. Churpek, Nameer Al Mardini, Ismael Shaukat, Sandeep Gurbuxani, Jonathan L. Miller & Lucy A. Godley
Pages: 2945-2946
Published online: 22 Apr 2014
CitationforA new family with a germline ANKRD26 mutation and predisposition to myeloid malignancies | Full Text | References | PDF (486.9 KB) | Supplemental
  • 560 Views
  • 25 CrossRef citations
  • 0Altmetric
Letter
Association between neutropenia and brain abscess due to Bacillus cereus bacteremia in patients with hematological malignancies
Tomotaka Ugai & Kosei Matsue
Pages: 2947-2949
Published online: 22 Apr 2014
First Page PreviewforAssociation between neutropenia and brain abscess due to Bacillus cereus bacteremia in patients with hematological malignancies | Full Text | References | PDF (143.3 KB) | Supplemental
  • 341 Views
  • 6 CrossRef citations
  • 0Altmetric
Letter
A 5-day outpatient regimen of azacitidine is effective and well tolerated in patients with acute myeloid leukemia unsuitable for intensive chemotherapy
Maeve A. O'Reilly, Cathy McHale, Ahmed Almazmi, Abdul Hameed, Dalia Benjamin, Niamh O'Connell, Philip Murphy, John Quinn, Patrick Thornton, Peter O'Gorman, Hana Frankova, Jeremy Sargent, Estelle Verburgh, John McHugh, Pamela Evans & Helen Enright
Pages: 2950-2951
Published online: 22 Apr 2014
CitationforA 5-day outpatient regimen of azacitidine is effective and well tolerated in patients with acute myeloid leukemia unsuitable for intensive chemotherapy | Full Text | References | PDF (89.2 KB) | Supplemental
  • 316 Views
  • 1 CrossRef citations
  • 0Altmetric
Letter
Visceral leishmaniasis mimicking Richter transformation
Ester M. Orlandi & Antonello Malfitano
Pages: 2952-2954
Published online: 25 Mar 2014
First Page PreviewforVisceral leishmaniasis mimicking Richter transformation | Full Text | References | PDF (197.8 KB) | Supplemental
  • 93 Views
  • 4 CrossRef citations
  • 0Altmetric
Letter
A study of gemcitabine, l-asparaginase, ifosfamide, dexamethasone and etoposide chemotherapy for newly diagnosed stage IV, relapsed or refractory extranodal natural killer/T-cell lymphoma, nasal type
Jie Ji, Ting Liu, Bing Xiang, Weiping Liu, Chuan He, Xinchuan Chen, Jianjun Li, Hong Chang, Yang Dai & Tian Dong
Pages: 2955-2957
Published online: 06 May 2014
First Page PreviewforA study of gemcitabine, l-asparaginase, ifosfamide, dexamethasone and etoposide chemotherapy for newly diagnosed stage IV, relapsed or refractory extranodal natural killer/T-cell lymphoma, nasal type | Full Text | References | PDF (220.2 KB) | Supplemental
  • 243 Views
  • 13 CrossRef citations
  • 0Altmetric
Letter
Extreme thrombocytosis in chronic myeloid leukemia in the era of tyrosine kinase inhibitors
Federica Sorà, Francesco Autore, Patrizia Chiusolo, Sara Marietti, Jolanta Bayer, Luca Laurenti, Sabrina Giammarco, Giuseppe Ausoni, Giuseppe Leone & Simona Sica
Pages: 2958-2960
Published online: 06 May 2014
First Page PreviewforExtreme thrombocytosis in chronic myeloid leukemia in the era of tyrosine kinase inhibitors | Full Text | References | PDF (124.8 KB) | Supplemental
  • 253 Views
  • 7 CrossRef citations
  • 0Altmetric
Letter
Absence of miR-142 mutation in Chinese patients with acute myeloid leukemia
Fei-Fei Chen, Yin-Jun Lou, Jian Chen, Jing Jin, Jia-Ni Zhou, Xiu-Feng Yin, Zhi-Juan Zhu, Chao Hu, Meng-Xia Yu, Huan-Ping Wang & Jie Jin
Pages: 2961-2962
Published online: 07 May 2014
CitationforAbsence of miR-142 mutation in Chinese patients with acute myeloid leukemia | Full Text | References | PDF (90.7 KB) | Supplemental
  • 155 Views
  • 2 CrossRef citations
  • 0Altmetric
Letter
Aggressive systemic mastocytosis mimicking lymphoma: description of an unusual presentation and review of the literature on current management strategies
Srinivas K. Tantravahi, Mohamad E. Salama & Michael N. W. Deininger
Pages: 2963-2966
Published online: 08 Apr 2014
First Page PreviewforAggressive systemic mastocytosis mimicking lymphoma: description of an unusual presentation and review of the literature on current management strategies | Full Text | References | PDF (413.3 KB) | Supplemental
  • 167 Views
  • 2 CrossRef citations
  • 0Altmetric
Letter
Visceral leishmaniasis in a patient with relapsed multiple myeloma receiving high-dose melphalan and autologous stem cell transplant
Aleksandar Radujkovic, Michael Hundemer, Christoph Eisenbach, Thomas Luft, Roland Penzel, Hartmut Goldschmidt, Anthony D. Ho & Frauke Bellos
Pages: 2967-2969
Published online: 16 Jun 2014
First Page PreviewforVisceral leishmaniasis in a patient with relapsed multiple myeloma receiving high-dose melphalan and autologous stem cell transplant | Full Text | References | PDF (237.4 KB) | Supplemental
  • 152 Views
  • 8 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

Long-term results of the sequential combination of cladribine and rituximab in Hairy cell leukemia
Jennifer Marvin-Peek et al.
Article | Published online: 15 May 2024
Mitigating time toxicity in lymphoma and multiple myeloma
Mengyang Di et al.
Review Article | Published online: 15 May 2024
Pharmacokinetics of idelalisib in chronic lymphocytic leukemia and follicular lymphoma disclose better outcomes for patients with lower exposure
Fabien Despas et al.
Letter to the Editor | Published online: 15 May 2024
Prevalence and clinicopathological features of incidentally detected TRBC1-dim populations in peripheral blood flow cytometry
Paul Wadsworth et al.
Letter to the Editor | Published online: 15 May 2024
View all latest articles